Roy C. Hardiman - Net Worth and Insider Trading
Roy C. Hardiman Net Worth
The estimated net worth of Roy C. Hardiman is at least $12 Million dollars as of 2024-11-29. Roy C. Hardiman is the Chief Business Officer of Principia Biopharma Inc and owns about 119,677 shares of Principia Biopharma Inc (PRNB) stock worth over $12 Million. Details can be seen in Roy C. Hardiman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Roy C. Hardiman has not made any transactions after 2020-09-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Roy C. Hardiman
Roy C. Hardiman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Roy C. Hardiman owns 1 companies in total, including Principia Biopharma Inc (PRNB) .
Click here to see the complete history of Roy C. Hardiman’s form 4 insider trades.
Insider Ownership Summary of Roy C. Hardiman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PRNB | Principia Biopharma Inc | 2020-09-28 | Chief Business Officer |
Roy C. Hardiman Latest Holdings Summary
Roy C. Hardiman currently owns a total of 1 stock. Roy C. Hardiman owns 119,677 shares of Principia Biopharma Inc (PRNB) as of September 18, 2020, with a value of $12 Million.
Latest Holdings of Roy C. Hardiman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PRNB | Principia Biopharma Inc | 2020-09-18 | 119,677 | 100.05 | 11,973,684 |
Holding Weightings of Roy C. Hardiman
Roy C. Hardiman Form 4 Trading Tracker
According to the SEC Form 4 filings, Roy C. Hardiman has made a total of 4 transactions in Principia Biopharma Inc (PRNB) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Principia Biopharma Inc is the sale of 5,000 shares on September 18, 2020, which brought Roy C. Hardiman around $499,900.
Insider Trading History of Roy C. Hardiman
- 1
Roy C. Hardiman Trading Performance
Roy C. Hardiman Ownership Network
Roy C. Hardiman Owned Company Details
What does Principia Biopharma Inc do?
Who are the key executives at Principia Biopharma Inc?
Roy C. Hardiman is the Chief Business Officer of Principia Biopharma Inc. Other key executives at Principia Biopharma Inc include Chief Medical Officer Dolca Thomas , Chief Development Officer Stefani Wolff , and Chief Scientific Officer David M Goldstein .
Principia Biopharma Inc (PRNB) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Principia Biopharma Inc (PRNB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Principia Biopharma Inc (PRNB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Principia Biopharma Inc (PRNB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Principia Biopharma Inc Insider Transactions
Roy C. Hardiman Mailing Address
Above is the net worth, insider trading, and ownership report for Roy C. Hardiman. You might contact Roy C. Hardiman via mailing address: C/o Pharmacyclics, Inc. 995 East Arques Avenue Sunnyvale Ca 94085.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
